Here we discuss the potential of this emerging therapy to improve both motor and non-motor symptoms of PD. We also highlight directions for future basic, translational, and clinical research that are critical for the development of mechanism-based protocols of light therapy in PD.
Parkinson's Disease and the Rationale of Light Therapy
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. PD is diagnosed primarily by progressive and age-dependent deterioration of motor functions (i.e., bradykinesia, resting tremor, muscular rigidity, and postural instability) [1] . Despite the primacy of this motor dysfunction in the clinical diagnosis of PD, patients with PD also display a wide range of nonmotor symptoms (NMSs) including sleep disturbances, cognitive deficits, sensory impairments, and psychiatric problems such as depression, anxiety, and psychosis [1] . In fact, at advanced stage of the disease, NMSs tend to dominate the clinical picture of PD and become the main determinants of the overall quality of life of PD patients and decisions on their institutionalization [1] . Currently, therapies that effectively target NMSs are lacking and, along with diseasemodifying treatments, this is a key unmet clinical need [1] . These challenges are in stark contrast to the highly efficacious therapies currently available for motor aspects of the disease [1] . In view of this, there is growing interest in the development of alternative treatment modalities for PD. Light therapy is one of these novel therapies [2] [3] [4] [5] [6] . The rationale of introducing light therapy to PD clinics resides in the well-documented therapeutic effect of bright light in other neurological and neuropsychiatric disorders [7] , some of which co-exist in PD patients [1] . Here, we briefly summarize the results of the early studies that assessed the efficacy and safety of light therapy in PD and discuss caveats that future clinical and fundamental research efforts need to address. We also highlight the potential of these fundamental insights in helping the development of more efficacious and mechanism-based protocols of light therapy in PD.
Therapeutic Effects of Light in PD
As a salient alternating environmental cue, light acts as one of the most powerful signals that influences our behaviour and health [7] . As such, over the past three decades, exposure to bright light has been used as a therapy to treat several disorders including mood disorders, cognitive disabilities, circadian misalignment, and alterations of sleepwake behaviour [7] . Building on this experience, bright light therapy (BLT) has been recently introduced to PD treatment with the perspective of improving the quality of life of PD patients. So far, only four studies have assessed the efficacy and safety of BLT in PD patients [2] [3] [4] [5] . Bright light pulses of intensities and durations ranging from 1000 to 10 000 lux and 30 min to 1.5 h, respectively, were used daily either in the morning (1 h after awakening [3] ) or in the evening (1 h before bedtime [2, 4] ) or twice daily [5] over varying periods, from 1 week to several months [2] [3] [4] [5] . The efficacy of BLT was assessed
